The Board granted an effective date of July 11, 2022, for a 30 percent rating for IBS with GERD and August 20, 2009, for a 10 percent rating for left wrist tendonitis. The claims for earlier effective dates for the 60 percent rating for psoriasis and 10 percent rating for right wrist tendonitis were denied.

The deciding factor: The decision was based on the date of claim and whether there was a factually ascertainable increase in severity within one year prior to the date of claim, as required by law.

Claimed conditions

Irritable Bowel Syndrome (IBS) with Gastroesophageal Reflux Disease (GERD), Psoriasis, Left Wrist Tendonitis, Right Wrist Tendonitis

How they argued it

Direct service connection

Exposure basis

None

Rating assigned

None in this decision

Decision date

October 15, 2025

Citation

A25088792

Want to see how appeals like this one tend to go? Appeals like mine